28.
Retatrutide phase 3 weight-loss results
Lilly’s highest retatrutide dose reportedly produced 28.3% average body-weight loss over 80 weeks, with 45% of patients losing at least 30%
1 appearance on the backlist front page in the last 30 days.
Lilly’s highest retatrutide dose reportedly produced 28.3% average body-weight loss over 80 weeks, with 45% of patients losing at least 30%